Open AccessLong-term lamivudine for chronic hepatitis B and cirrhosis: A real-life cohort study
Author(s) -
Minghua Su,
Ai-Lian Lu,
Shihua Li,
Shao-Hua Zhong,
Baojian Wang,
Xiaoli Wu,
Yan-Yan Mo,
Liang Peng,
Zhihong Liu,
Xie Rong,
Limin He,
Wu-Dao Fu,
Jianning Jiang
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i46.13087
Subject(s) - medicine , lamivudine , gastroenterology , cumulative incidence , cirrhosis , hepatocellular carcinoma , alanine transaminase , hepatitis b , regimen , prospective cohort study , hepatitis b virus , cohort , surgery , immunology , virus
To investigate clinical outcomes of chronic hepatitis B (CHB) and liver cirrhosis (LC) patients under whole-course management with lamivudine (LAM).